Our digital journey is evolving into intelligent transformation - embedding intelligence, data, and advanced technologies across the pharmaceutical value chain. From research and manufacturing to quality, supply chain, and commercial operations, we are integrating AI, advanced analytics, automation, and connected platforms to enhance how we operate and deliver healthcare outcomes.
Guided by a data-first and AI-powered approach, our transformation is focused on improving operational agility, strengthening product quality, and enabling faster, insight-driven decision-making across the enterprise.
AI and advanced analytics are becoming powerful enablers of operational efficiency at Lupin. By transforming data into actionable insights, these technologies are improving productivity and supporting better healthcare outcomes.
The key areas of impact include:
We are strengthening our manufacturing ecosystem through connected technologies and real-time operational visibility. At our Nagpur Unit-1 OSD and Tarapur facilities, Industrial Internet of Things (IIoT) video walls display live operational parameters across critical processes including compression, fluid bed drying, granulation, and coating. These capabilities allow our teams to:
At Tarapur, equipment sensors feed directly into the IIoT ecosystem, enabling predictive insights and proactive course correction.
Additionally, PAS-X Manufacturing Execution System (MES) dashboards provide a unified view of batch progress, improving visibility, productivity, and cross-functional coordination across manufacturing teams.
A key enabler of our digital transformation is the global deployment of SAP S/4HANA, a next-generation enterprise platform that integrates real-time data across supply-chain, manufacturing, sales, and workforce operations. The platform now supports operations across 100+ countries and 15 major sites, creating a unified digital backbone for enterprise decision-making. To enhance accessibility and user experience:
In addition, an integrated global supply planning platform strengthens demand forecasting and cross-functional coordination, ensuring the timely delivery of medicines worldwide.
As we advance our intelligent enterprise capabilities, digital trust and cybersecurity remain foundational priorities.
Our key initiatives include:
These efforts resulted in zero major cybersecurity incidents in FY25, while strengthening governance through board-level oversight and predictive risk monitoring frameworks.
Our investments in intelligent technologies are generating measurable operational value. In FY25, our digital initiatives enabled:
Operational improvements were realized across multiple functions:
Our journey towards digital transformation continues as we scale AI, automation, and advanced analytics across the enterprise. By combining technology with deep scientific expertise, we are building a connected digital ecosystem that enhances productivity, strengthens quality, and accelerates innovation.
As these capabilities expand globally, intelligent technologies will remain central to how we advance operational excellence and deliver better healthcare outcomes for patients worldwide.
